Post by Carla Lanรงa

Research Associate

๐™ƒ๐™ค๐™ฌ ๐™˜๐™ก๐™ค๐™จ๐™š ๐™–๐™ง๐™š ๐™ฌ๐™š ๐™ฉ๐™ค ๐™ฅ๐™š๐™ง๐™จ๐™ค๐™ฃ๐™–๐™ก๐™ž๐™จ๐™š๐™™ ๐™ข๐™ฎ๐™ค๐™ฅ๐™ž๐™– ๐™ข๐™–๐™ฃ๐™–๐™œ๐™š๐™ข๐™š๐™ฃ๐™ฉ? Clinical practice in myopia has evolved considerably over the past decade, with an expanding range of interventions now available to prevent myopia onset and slow its progression. However, many important questions remain. How can we prevent myopia in todayโ€™s environment? How can we reduce the risk of progression to high myopia and pathologic myopia? Can personalised treatment strategies help to achieve better outcomes? These are some of the questions that inspired the new topical collection,ย Emerging and Personalised Approaches to Myopia Prevention and Management, inย Ophthalmology and Therapy: https://lnkd.in/dZJxARhk It is a privilege to serve as Editor alongside Andrzej Grzybowski and Seang Mei SAW ่‹็ฅฅ็พŽ. We welcome submissions that contribute to advancing evidence-based, personalised approaches to myopia prevention and management. #Myopia #MyopiaManagement #PathologicMyopia #HighMyopia #Ophthalmology #Optometry #VisionScience #PublicHealth #Research

Post content